Molecular interaction between caveolin-1 and ABCA1 on high-density lipoprotein-mediated cholesterol efflux in aortic endothelial cells

Cardiovascular Research

Volumn 75, Issue 3, 2007, Pages 575-583

  Lin, Yu Chun ^a   Ma, Chang ^a   Hsu, Wei Ching ^a   Lo, Hsiao Fan ^a   Yang, Vivian C ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

ABCA1; Aortic endothelial cells; Caveolin 1; Cholesterol efflux; HDL

Indexed keywords

ABC TRANSPORTER A1; CAVEOLIN 1; COMPLEMENTARY DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METHYL BETA CYCLODEXTRIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CAVEOLA; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSFECTION; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; LIPID TRANSPORT; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; AORTA; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CAVEOLIN 1; CELL MEMBRANE; CELLS, CULTURED; CHOLESTEROL; CYTOPLASM; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; LIPOPROTEINS, HDL; MICROSCOPY, FLUORESCENCE; MICROSCOPY, IMMUNOELECTRON; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSDUCTION, GENETIC;

EID: 34447531942     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.04.012     Document Type: Article

References (33)

1. Fielding C.J., and Fielding P.E. Cholesterol and caveolae: structural and functional relationships. Biochim Biophys Acta 1529 (2000) 210-222
2. Fielding C.J., and Fielding P.E. Caveolae and intracellular trafficking of cholesterol. Adv Drug Deliv Rev 49 (2001) 251-264
3. Smart E.J., Ying Y.-S., Donzell W.C., and Anderson R.G.W. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 271 (1996) 29427-29435
4. Fielding C.J., Bist A., and Fielding P.E. Intracellular cholesterol transport in synchronized human skin fibroblasts. Biochemistry 38 (1999) 2506-2513
5. Frank P.G., Galbiati F., Volonte D., Razani D., Cohen D.E., Marcel Y.L., et al. Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am J Physiol 280 (2001) C1204-C1214
6. Matveev S., Uittenbogaard A., van Der Westhuyzen D., and Smart E.J. Caveolin-1 negatively regulates SR-BI mediated selective uptake of high-density lipoprotein-derived cholesteryl ester. Eur J Biochem 268 (2001) 5609-5616
7. Wang L., Connelly M.A., Ostermeyer A.G., Chen H.-H., Williams D.L., and Brown D.A. Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines. J Lipid Res 44 (2003) 807-815
8. Frank P.G., Marcel Y.L., Connelly M.A., Lublin D.M., Franklin V., Williams D.L., et al. Stabilization of caveolin-1 by cellular cholesterol and scavenger receptor class B type I. Biochemistry 41 (2002) 11931-11940
9. Wang N., Silver D.L., Costet P., and Tall A.R. Specific binding of apoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 275 42 (2000) 33053-33058
10. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22 4 (1999) 352-355
11. Schaefer E.J., Zech L.A., Schwartz D.E., and Brewer Jr. H.B. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med 93 (1980) 261-266
12. Von Der Thusen J.H., Kuiper J., Fekkes M.L., De Vos P., Van Berkel T.J., and Biessen E.A. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 15 14 (2001) 2730-2732
13. Arakawa R., Abe-Dohmae S., Asai M., Ito J.I., and Yokoyama S. Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells. J Lipid Res 41 (2000) 1952-1962
14. Chao W.T., Tsai S.H., Lin Y.C., Lin W.W., and Yang V.C. Cellular localization and interaction of ABCA1 and caveolin-1 in aortic endothelial cells after HDL incubation. Biochem Biophys Res Commun 332 (2005) 743-749
15. Chao W.T., Fan S.S., and Yang V.C. Visualization of the uptake of high-density lipoprotein by rat aortic endothelial cells and smooth muscle cells in vitro. Histochem J 34 (2002) 232-239
16. Wu C.A., Tsujita M., Hayashi M., and Yokoyama S. Probucol inactivates ABCA1 in the plasma membrane with respect to its mediation of apolipoprotein binding and high density lipoprotein assembly and to its proteolytic degradation. J Biol Chem 279 (2004) 30168-30174
17. Fielding P.E., and Fielding C.J. Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34 (1995) 14288-14292
18. Luciani M.F., Denizot F., Savary S., Mattei M.G., and Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 21 (1994) 150-159
19. Neufeld E.B., Stonik J.A., Demosky Jr. S.J., Knapper C.L., Combs C.A., et al. The ABCA1 transporter modulates late endocytic trafficking: insight from the correction of the genetic defect in Tangier disease. J Biol Chem 279 (2004) 15571-15578
20. Orso E., Broccardo C., Kaminski W.E., Bottcher A., Liebisch G., Drobnik W., et al. Transport of lipids from golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat Genet 24 (2000) 192-196
21. Fu Y., Hoang A., Escher G., Parton R.G., Krozowski Z., and Sviridov D. Expression of caveolin-1 enhances cholesterol efflux in hepatic cells. J Biol Chem 279 (2004) 14140-14146
22. Neufeld E.B., Remaley A.T., Demosky S.J., Stonik J.A., Cooney A.M., Comly M., et al. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 276 (2001) 27584-27590
23. Le Goff W., Peng D.-Q., Settle M., Brubaker G., Morton R.E., and Smith J.D. Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I. Arterioscler Thromb Vasc Biol 24 (2004) 2155-2161
24. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., and Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23 (2003) 712-719
25. O'Connell B.J., Denis M., and Genest J. Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation 110 (2004) 2881-2888
26. Liao H., Langmann T., Schmitz G., and Zhu Y. Native LDL upregulation of ATP-binding cassette transporter-1 in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 22 (2002) 127-132
27. Ji Y., Jian B., Wang N., Sun Y., Moya M.L., Phillips M.C., et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272 (1997) 20982-20985
28. Escher G., Krozowski Z., Croft K.D., and Sviridov D. Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. J Biol Chem 278 (2003) 11015-11019
29. Uittenbogaard A., Ying Y.-S., and Smart E.J. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. J Biol Chem 273 (1998) 6525-6532
30. Kurzchalia T.V., Dupree P., and Monier S. VIP21-caveolin, a protein of the trans-Golgi network and caveolae. FEBS Lett 346 (1994) 88-91
31. Mollenhauer H.H., Morre D.J., and Rowe L.D. Alteration of intracellular traffick by monensin; mechanism, specificity and relationship to toxicity. Biochim Biophys Acta 1031 (1990) 225-246
32. Klausner R.D., Donaldson J.G., and Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116 (1992) 1071-1080
33. Mendez A.J. Monensin and brefeldin A inhibit high density lipoprotein-mediated cholesterol efflux from cholesterol-enriched cells. J Biol Chem (1995) 5891-5900